EMMES has promoted executive vice president Dr. Anne Lindblad to president and chief executive officer. Lindblad replaces Dr. Donald (Don) Stablein, who has been named past president. Stablein, who joined the company in 1980, has been president/CEO since 1992. In his new role as past president, he will continue to provide project support and will be an ambassador for EMMES.

A biostatistician with experience in clinical design and project management, Lindblad became EMMES vice president in 1992 and executive vice president in 2006. During her 30 years at EMMES, she has led projects in ophthalmology, oncology, nephrology, transplantation, neurology, stroke, traumatic brain injury, dental disease and swallowing disorders. She has been a reviewer of grant and contract applications for the NIH and has chaired or worked on Data and Safety Monitoring Committees in multiple disease areas. In addition, she has been on the board of directors and president of the Society for Clinical Trials.